微信小陈
微信小章| 产品名称： | Amycolatopsis rifamycinica Bala et al. |
|---|---|
| 商品货号： | TS175698 |
| Deposited As： | Nocardia mediterranei (Margalith and Beretta) Thiemann et al. |
| Strain Designations： | NT 19 DSM 46095 |
| Application： | Produces rifamycin SV |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Preceptrol®： | no |
| Type Strain： | yes
Ref  Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283 |
| Medium： | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions： | Temperature: 26.0°C |
| Name of Depositor： | EH Baxter |
| References： | Birner J, et al. An Australian isolate of Nocardia mediterranea producing rifamycin SV. J. Antibiot. 25: 356-359, 1972. PubMed: 4649865 Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283 Bala S, et al. Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.. Int. J. Syst. Evol. Microbiol. 54: 1145-1149, 2004. PubMed: 15280283 |